{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:31:54Z","timestamp":1793338314069,"version":"4.5.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"17","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"crossref","award":["PLBIO 2020-010"],"award-info":[{"award-number":["PLBIO 2020-010"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"crossref","award":["DIALAML"],"award-info":[{"award-number":["DIALAML"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Investissement d'Avenir PSPC","award":["IMODI"],"award-info":[{"award-number":["IMODI"]}]},{"name":"Laboratoire d'Excellence Toulouse Cancer","award":["TOUCAN and TOUCAN2.0 ANR11-LABEX"],"award-info":[{"award-number":["TOUCAN and TOUCAN2.0 ANR11-LABEX"]}]},{"DOI":"10.13039\/501100019164","name":"Fondation Toulouse Cancer Sant\u00e9","doi-asserted-by":"crossref","award":["BADIPAML"],"award-info":[{"award-number":["BADIPAML"]}],"id":[{"id":"10.13039\/501100019164","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canceropole Grand Sud Ouest"},{"DOI":"10.13039\/501100004099","name":"Ligue Nationale Contre le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Association Prolific"},{"name":"Association GAEL"},{"name":"European Regional Development Fund Interreg V-A Spain France Andorra","award":["PROTEOblood EFA360\/19"],"award-info":[{"award-number":["PROTEOblood EFA360\/19"]}]},{"name":"Agence Nationale de la Recherche - Investissement d'avenir","award":["ANR-11-PHUC-001 CAPTOR"],"award-info":[{"award-number":["ANR-11-PHUC-001 CAPTOR"]}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"crossref","award":["ANR-21-CE14-0057-01"],"award-info":[{"award-number":["ANR-21-CE14-0057-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Identifying mechanisms underlying relapse is a major clinical issue for effective cancer treatment. The emerging understanding of the importance of metastasis in hematologic malignancies suggests that it could also play a role in drug resistance and relapse in acute myeloid leukemia (AML). In a cohort of 1,273 AML patients, we uncovered that the multifunctional scavenger receptor CD36 was positively associated with extramedullary dissemination of leukemic blasts, increased risk of relapse after intensive chemotherapy, and reduced event-free and overall survival. CD36 was dispensable for lipid uptake but fostered blast migration through its binding with thrombospondin-1. CD36-expressing blasts, which were largely enriched after chemotherapy, exhibited a senescent-like phenotype while maintaining their migratory ability. In xenograft mouse models, CD36 inhibition reduced metastasis of blasts and prolonged survival of chemotherapy-treated mice. These results pave the way for the development of CD36 as an independent marker of poor prognosis in AML patients and a promising actionable target to improve the outcome of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>CD36 promotes blast migration and extramedullary disease in acute myeloid leukemia and represents a critical target that can be exploited for clinical prognosis and patient treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-22-3682","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T15:36:08Z","timestamp":1686929768000},"page":"2824-2838","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia"],"prefix":"10.1158","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4390-8073","authenticated-orcid":false,"given":"Thomas","family":"Farge","sequence":"first","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."},{"name":"4Institute of Metabolic and Cardiovascular Diseases, Team CERAMIC, INSERM, Paul Sabatier University, UMR1297, Toulouse, France."},{"name":"5Institut F\u00e9d\u00e9ratif de Biologie (IFB), CHU Toulouse, Toulouse, France."},{"name":"6RESTORE Research Center, Universit\u00e9 Toulouse Paul Sabatier, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9385-6577","authenticated-orcid":false,"given":"Jean","family":"Nakhle","sequence":"additional","affiliation":[{"name":"6RESTORE Research Center, Universit\u00e9 Toulouse Paul Sabatier, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6922-8642","authenticated-orcid":false,"given":"Damien","family":"Lagarde","sequence":"additional","affiliation":[{"name":"6RESTORE Research Center, Universit\u00e9 Toulouse Paul Sabatier, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France."},{"name":"7McGill University, Rosalind and Morris Goodman Cancer Institute, Montr\u00e9al, Qu\u00e9bec, Canada."},{"name":"8McGill University, Department of Biochemistry, Montr\u00e9al, Qu\u00e9bec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-8110","authenticated-orcid":false,"given":"Guillaume","family":"Cognet","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6838-7168","authenticated-orcid":false,"given":"Nathaniel","family":"Polley","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0152-985X","authenticated-orcid":false,"given":"R\u00e9my","family":"Castellano","sequence":"additional","affiliation":[{"name":"9Centre de Recherche en Canc\u00e9rologie de Marseille, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 13009 Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1659-7596","authenticated-orcid":false,"given":"Marie-Laure","family":"Nicolau","sequence":"additional","affiliation":[{"name":"10University of Toulouse, Toulouse, France."},{"name":"11Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'H\u00e9matologie, Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1435-3475","authenticated-orcid":false,"given":"Claudie","family":"Bosc","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7673-4842","authenticated-orcid":false,"given":"Marie","family":"Sabatier","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4755-2884","authenticated-orcid":false,"given":"Ambrine","family":"Sahal","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8521-3061","authenticated-orcid":false,"given":"Estelle","family":"Saland","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5325-3130","authenticated-orcid":false,"given":"Yannick","family":"Jeanson","sequence":"additional","affiliation":[{"name":"6RESTORE Research Center, Universit\u00e9 Toulouse Paul Sabatier, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7721-1312","authenticated-orcid":false,"given":"Nathan","family":"Guiraud","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-8692","authenticated-orcid":false,"given":"Emeline","family":"Boet","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1394-7677","authenticated-orcid":false,"given":"Camille","family":"Bergoglio","sequence":"additional","affiliation":[{"name":"12Institute of Metabolic and Cardiovascular Diseases, Team MetaDiab, INSERM, Paul Sabatier University, UMR1297, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4764-2142","authenticated-orcid":false,"given":"Mathilde","family":"Gotan\u00e8gre","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7832-9146","authenticated-orcid":false,"given":"Pierre-Luc","family":"Mouchel","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."},{"name":"10University of Toulouse, Toulouse, France."},{"name":"11Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'H\u00e9matologie, Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-981X","authenticated-orcid":false,"given":"Lucille","family":"Stuani","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5827-8433","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Larrue","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6797-4835","authenticated-orcid":false,"given":"Marie","family":"Sallese","sequence":"additional","affiliation":[{"name":"6RESTORE Research Center, Universit\u00e9 Toulouse Paul Sabatier, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1878-9129","authenticated-orcid":false,"given":"V\u00e9ronique","family":"De Mas","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."},{"name":"10University of Toulouse, Toulouse, France."},{"name":"11Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'H\u00e9matologie, Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4294-0597","authenticated-orcid":false,"given":"Cedric","family":"Moro","sequence":"additional","affiliation":[{"name":"12Institute of Metabolic and Cardiovascular Diseases, Team MetaDiab, INSERM, Paul Sabatier University, UMR1297, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4712-791X","authenticated-orcid":false,"given":"C\u00e9dric","family":"Dray","sequence":"additional","affiliation":[{"name":"6RESTORE Research Center, Universit\u00e9 Toulouse Paul Sabatier, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-7099","authenticated-orcid":false,"given":"Yves","family":"Collette","sequence":"additional","affiliation":[{"name":"9Centre de Recherche en Canc\u00e9rologie de Marseille, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 13009 Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8723-5472","authenticated-orcid":false,"given":"Isabelle","family":"Raymond-Letron","sequence":"additional","affiliation":[{"name":"6RESTORE Research Center, Universit\u00e9 Toulouse Paul Sabatier, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France."},{"name":"13LabHPEC, Universit\u00e9 de Toulouse, ENVT, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5103-8509","authenticated-orcid":false,"given":"Isabelle","family":"Ader","sequence":"additional","affiliation":[{"name":"6RESTORE Research Center, Universit\u00e9 Toulouse Paul Sabatier, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-4525","authenticated-orcid":false,"given":"Christian","family":"R\u00e9cher","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."},{"name":"10University of Toulouse, Toulouse, France."},{"name":"11Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'H\u00e9matologie, Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-2032","authenticated-orcid":false,"given":"Jean-Emmanuel","family":"Sarry","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6149-082X","authenticated-orcid":false,"given":"Florence","family":"Cabon","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-4404","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Vergez","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, Inserm, CNRS, Toulouse, France."},{"name":"2LabEx Toucan, Toulouse, France."},{"name":"3Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer 2023, Toulouse, France."},{"name":"10University of Toulouse, Toulouse, France."},{"name":"11Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'H\u00e9matologie, Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4277-7905","authenticated-orcid":false,"given":"Audrey","family":"Carri\u00e8re","sequence":"additional","affiliation":[{"name":"6RESTORE Research Center, Universit\u00e9 Toulouse Paul Sabatier, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"2025112418024073100_bib1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"2025112418024073100_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","article-title":"Advances in the treatment of acute myeloid leukemia: new drugs and new challenges","volume":"10","author":"Short","year":"2020","journal-title":"Cancer Discov"},{"key":"2025112418024073100_bib3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"key":"2025112418024073100_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccell.2018.08.007","article-title":"Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence","volume":"34","author":"Boyd","year":"2018","journal-title":"Cancer Cell"},{"key":"2025112418024073100_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2020.07.009","article-title":"Induction of a timed metabolic collapse to overcome cancer chemoresistance","volume":"32","author":"van Gastel","year":"2020","journal-title":"Cell Metab"},{"key":"2025112418024073100_bib6","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","article-title":"Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis","volume":"37","author":"Ladanyi","year":"2018","journal-title":"Oncogene"},{"key":"2025112418024073100_bib7","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1016\/j.celrep.2019.11.008","article-title":"CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies","volume":"29","author":"Feng","year":"2019","journal-title":"Cell Rep"},{"key":"2025112418024073100_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2025112418024073100_bib9","doi-asserted-by":"crossref","first-page":"11811","DOI":"10.1016\/S0021-9258(19)50272-1","article-title":"CD36 is a receptor for oxidized low density lipoprotein","volume":"268","author":"Endemann","year":"1993","journal-title":"J Biol Chem"},{"key":"2025112418024073100_bib10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI112918","article-title":"Isolation of the thrombospondin membrane receptor","volume":"79","author":"Asch","year":"1987","journal-title":"J Clin Invest"},{"key":"2025112418024073100_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12967-019-2098-6","article-title":"CD36 promotes the epithelial-mesenchymal transition and metastasis in cervical cancer by interacting with TGF-beta","volume":"17","author":"Deng","year":"2019","journal-title":"J Transl Med"},{"key":"2025112418024073100_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"key":"2025112418024073100_bib13","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.272re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein","year":"2009","journal-title":"Sci Signal"},{"key":"2025112418024073100_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/2159-8290.CD-20-0318","article-title":"The hepatic microenvironment uniquely protects leukemia cells through induction of growth and survival pathways mediated by LIPG","volume":"11","author":"Ye","year":"2021","journal-title":"Cancer Discov"},{"key":"2025112418024073100_bib15","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","article-title":"Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence","volume":"11","author":"Duy","year":"2021","journal-title":"Cancer Discov"},{"key":"2025112418024073100_bib16","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1038\/s41388-021-02027-6","article-title":"IER2-induced senescence drives melanoma invasion through osteopontin","volume":"40","author":"Kyjacova","year":"2021","journal-title":"Oncogene"},{"key":"2025112418024073100_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","article-title":"Leukaemia: a model metastatic disease","volume":"21","author":"Whiteley","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"2025112418024073100_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.leukres.2004.01.006","article-title":"Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome","volume":"28","author":"Chang","year":"2004","journal-title":"Leuk Res"},{"key":"2025112418024073100_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ejh.12085","article-title":"Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET","volume":"90","author":"Cribe","year":"2013","journal-title":"Eur J Haematol"},{"key":"2025112418024073100_bib20","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN cancer research group trials, 1980\u20132008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J Clin Oncol"},{"key":"2025112418024073100_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.1997.15.2.466","article-title":"Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from cancer and leukemia group B 8461","volume":"15","author":"Byrd","year":"1997","journal-title":"J Clin Oncol"},{"key":"2025112418024073100_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J Hematol Oncol"},{"key":"2025112418024073100_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"2025112418024073100_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"Dohner","year":"2010","journal-title":"Blood"},{"key":"2025112418024073100_bib25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41408-017-0011-1","article-title":"Improved outcome for AML patients over the years 2000\u20132014","volume":"7","author":"Bertoli","year":"2017","journal-title":"Blood Cancer J"},{"key":"2025112418024073100_bib26","doi-asserted-by":"crossref","first-page":"38310","DOI":"10.1038\/srep38310","article-title":"Perilipin 5 fine-tunes lipid oxidation to metabolic demand and protects against lipotoxicity in skeletal muscle","volume":"6","author":"Laurens","year":"2016","journal-title":"Sci Rep"},{"key":"2025112418024073100_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3324\/haematol.13299","article-title":"Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling","volume":"94","author":"Verhaak","year":"2009","journal-title":"Haematologica"},{"key":"2025112418024073100_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"2025112418024073100_bib29","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"N Engl J Med"},{"key":"2025112418024073100_bib30","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1182\/blood-2012-09-459313","article-title":"Genomic impact of transient low-dose decitabine treatment on primary AML cells","volume":"121","author":"Klco","year":"2013","journal-title":"Blood"},{"key":"2025112418024073100_bib31","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1167\/iovs.05-1656","article-title":"Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization","volume":"47","author":"Mwaikambo","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025112418024073100_bib32","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/ATVBAHA.113.301523","article-title":"Molecular basis of antiangiogenic thrombospondin-1 type 1 repeat domain interactions with CD36","volume":"33","author":"Klenotic","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025112418024073100_bib33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41467-019-14262-3","article-title":"TGFbeta2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells","volume":"11","author":"Corbet","year":"2020","journal-title":"Nat Commun"},{"key":"2025112418024073100_bib34","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1538-7836.2011.04416.x","article-title":"Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein","volume":"9","author":"Nergiz-Unal","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2025112418024073100_bib35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1749-6632.2001.tb03961.x","article-title":"CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products","volume":"947","author":"Ohgami","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"2025112418024073100_bib36","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood.2020005382","article-title":"Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets","volume":"137","author":"Aburima","year":"2021","journal-title":"Blood"},{"key":"2025112418024073100_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41419-020-2434-z","article-title":"Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells","volume":"11","author":"Gong","year":"2020","journal-title":"Cell Death Dis"},{"key":"2025112418024073100_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2004-822977","article-title":"Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis","volume":"30","author":"Sargiannidou","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"2025112418024073100_bib39","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.1158\/0008-5472.CAN-11-0833","article-title":"Thrombospondin-1 triggers cell migration and development of advanced prostate tumors","volume":"71","author":"Firlej","year":"2011","journal-title":"Cancer Res"},{"key":"2025112418024073100_bib40","doi-asserted-by":"crossref","first-page":"75881","DOI":"10.18632\/oncotarget.17427","article-title":"Thrombospondin-1 promotes cell migration, invasion and lung metastasis of osteosarcoma through FAK dependent pathway","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"2025112418024073100_bib41","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.biocel.2013.07.004","article-title":"Bystander senescence in human peritoneal mesothelium and fibroblasts is related to thrombospondin-1-dependent activation of transforming growth factor-beta1","volume":"45","author":"Mikula-Pietrasik","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"2025112418024073100_bib42","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s43018-021-00264-y","article-title":"Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia","volume":"2","author":"Bosc","year":"2021","journal-title":"Nat Cancer"},{"key":"2025112418024073100_bib43","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood-2016-08-734798","article-title":"Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment","volume":"129","author":"Shafat","year":"2017","journal-title":"Blood"},{"key":"2025112418024073100_bib44","doi-asserted-by":"crossref","first-page":"113112","DOI":"10.1016\/j.yexcr.2022.113112","article-title":"IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia","volume":"415","author":"Zhang","year":"2022","journal-title":"Exp Cell Res"},{"key":"2025112418024073100_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ccell.2016.05.011","article-title":"MLL-AF9 expression in hematopoietic stem cells drives a highly invasive AML expressing EMT-related genes linked to poor outcome","volume":"30","author":"Stavropoulou","year":"2016","journal-title":"Cancer Cell"},{"key":"2025112418024073100_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.leu.2403190","article-title":"Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H","volume":"18","author":"Montillo","year":"2004","journal-title":"Leukemia"},{"key":"2025112418024073100_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1158\/2643-3230.BCD-19-0077","article-title":"Apolipoprotein C2-CD36 promotes leukemia growth and presents a targetable axis in acute myeloid leukemia","volume":"1","author":"Zhang","year":"2020","journal-title":"Blood Cancer Discov"},{"key":"2025112418024073100_bib48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41586-022-05535-x","article-title":"Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration","volume":"613","author":"Moiseeva","year":"2023","journal-title":"Nature"},{"key":"2025112418024073100_bib49","doi-asserted-by":"crossref","first-page":"e45274","DOI":"10.15252\/embr.201745274","article-title":"CD36 initiates the secretory phenotype during the establishment of cellular senescence","volume":"19","author":"Chong","year":"2018","journal-title":"EMBO Rep"},{"key":"2025112418024073100_bib50","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.leukres.2005.02.015","article-title":"Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients","volume":"29","author":"Perea","year":"2005","journal-title":"Leuk Res"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-22-3682\/3340863\/can-22-3682.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/83\/17\/2824\/3358883\/2824.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/83\/17\/2824\/3358883\/2824.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T23:03:06Z","timestamp":1764025386000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/83\/17\/2824\/728593\/CD36-Drives-Metastasis-and-Relapse-in-Acute"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":50,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,6,16]]},"published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-22-3682","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.24071643.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071646.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071637.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028294","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071634","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028282","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071628.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071646","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028291.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701285","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701273","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071628","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028282.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028279","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028285.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028288.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028294.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701267","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701279","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028273.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028276.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028273","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071625.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028285","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028291","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071631","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071643","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071637","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028279.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701288","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701276","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071649","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071625","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071631.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028276","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27028288","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071649.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701270","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701282","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24071634.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6816237","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6816237.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6816237.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}